Silymar 0.1 N30 tablets

Dosage form

Tablets are round, biconvex, from light brown to brown, interspersed.

Structure

Silymar extract dry (milk thistle extract dry) containing the sum of flavolignans in terms of silybin and absolutely dry matter 65% - 0.100 g

Excipients (milk sugar (lactose), potato starch, magnesium stearate) - the amount before the deposit until a tablet weighing 0.2 g is obtained

general description

Hepatoprotector

Special conditions

It is not recommended to use the drug during pregnancy, lactation and children under 12 years of age.

Drug interactions

Data on drug interactions of the drug Silimar are not provided.

Pharmacodynamics

The main active ingredients of Silymar ® are flavolignans obtained from the fruit of the milk thistle Silybum marianum (L.) Gaerth.

this

aster - Asteraceae.

The drug has a hepatoprotective and antitoxic effect.

The therapeutic effect is due to the effect on the metabolism of hepatocytes.

Activates the synthesis of proteins and enzymes in hepatocytes, has a stabilizing effect on the membrane of hepatocytes, inhibits the penetration of toxins into the liver cells, inhibits dystrophic and potentiates the regenerative processes of the liver

Indications

Silymar ® is taken for toxic liver damage, chronic hepatitis, liver cirrhosis (as part of complex therapy), after hepatitis.

Prophylactically used for chronic intoxication (including professional), long-term use of drugs and alcohol.

Contraindications

Individual intolerance.

Overdose

Data on overdose of the drug Silimar are not provided.

Side effects

Allergic reactions are possible, in some cases a laxative effect.

Dosage

100mg

Indications

Toxic liver damage

chronic hepatitis

cirrhosis of the liver (as part of complex therapy)

condition after hepatitis

for the purpose of prophylaxis in case of chronic intoxication (including professional), long-term intake of drugs and alcohol.

Contraindications

Hypersensitivity to drug components.

Storage conditions and periods

In a dark place at a temperature not exceeding 25 degrees.

Expiration date: 5 years

INN / Active ingredient

Silibinin

Specifications

Category

Hepatoprotectors

Scope of the drug

Gastrointestinal tract

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

thirty

Vacation conditions

Without recipe

The amount of the dosage form in the primary package

15 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Herbal hepatoprotective agent

Anatomical and therapeutic characteristics

A05BA03 Silymarin

Dosage form

Pills

Dosage (volume) of the substance in the preparation

milk thistle fruit extract - 100 mg

Expiration date in days

1825

Package weight, g

twenty